|

by Eddie McLaughlin, Man Cheung, John Davies & Richard Waterer
A growing number of companies now recognize that risk
can create valuable upside in their businesses when it is
managed effectively. A company that understands how
risk might impact its key performance indicators can
move more effectively to seize opportunities and drive
business performance. The strategies that companies
develop for financing risk are an important part of this
process. By simply buying insurance, companies probably
miss an opportunity to extract better value from capital
in their businesses.
Companies that take a more sophisticated approach to
understanding their optimal risk-financing arrangements
typically see a sustainable and lower total cost of risk
in their businesses. At Marsh, we call the process that
underpins this approach Risk Transfer Optimization.
This article sets out the rationale for Risk Transfer
Optimization and outlines the key stages that successful
companies follow to ensure that they are not only
providing adequate financial protection against their
businesses’ exposures, but are also optimizing the cost
of capital.
Risk Transfer Optimization describes the strategic process
undertaken by a growing number of firms in order to make
balanced and objective decisions around the allocation of
capital to risk. Its fundamental principles are:
1. It considers the purchasing of insurance as only one
of a number of tactics that can be deployed as part of
a broader, often longer-term risk management and
financing strategy. Risk Transfer Optimization is
about more than the limits and deductibles of an
insurance policy, although this often forms part of
a company’s considerations.
2. It treats insurance and risk financing spend as a form of
capital allocation, with the potential to work harder for a
company and deliver a higher return when allocated in
a more optimal way.
3. Ultimately it describes the matching of a company’s
buying style with its appetite to take risk, the losses it is
likely to sustain, and the cost of capital associated with
its various financing options.
A company that previously treated risk transfer as no more
than a series of annualized insurance transactions may
wish to re-evaluate this position for financial, business and
professional reasons.
Financially, the acknowledged volatility of the insurance
market means that a company relying solely on insurance
to finance its exposures is at the mercy of the broader
market cycles and has to be prepared for its insurance
costs to fluctuate year-on-year. This issue can be
exacerbated when a sudden rise in the number or value
of claims has a material impact on the company’s future
cost of insurance cover.
Some organizations have happily bought the same levels
of insurance for years, without considering alternative
ways in which their risks can be financed, on or off balance
sheet, through an alternative vehicle. Over that time the
cost of purchasing insurance may have become more
expensive in relative terms than the cost of capital for
retaining the risk – either because of changes to the cost
and availability of insurance, changes to the strategy or
financial model of the company, or a blend of both. It is
only through evaluating and balancing this broader view
of the cost components of risk – known as Total Cost of
Risk (TCOR) – that companies can begin to understand
whether capital is being effectively deployed and value
continues to be created from risk-financing decisions.
From a business perspective, a longer-term view of the
risk-transfer strategy of a company provides a framework
for senior managers to dialogue more openly about risk
and the issues that might prevent them from successfully
achieving their objectives. The benefits from this can be
significant. Insurance coverage can be accurately matched
to exposures and loss expectancies. Uninsurable exposures
can be identified and assessed, and alternative forms of
financing arranged to manage potentially major losses.
Areas on which to focus risk improvement or management
activity can be identified, with the investment budget
determined by or even offset against the potential
reduction in losses or savings in risk transfer.
Finally, from a professional perspective, modern-day risk
managers have an opportunity to determine and underline
the value they are contributing to the firm by closely
aligning overall strategy and performance indicators with
the criteria they follow for risk and insurance decision
making. Risk managers who can unequivocally evidence
that the decisions they make are on the basis of businessrelevant
and objective data stand to minimize costs,
reduce volatility and build meaningful and long-term
relationships with the executive board, insurance markets
and brokers.
Risk Transfer Optimization can appear to be a complex
process, including within it a wider review of all business
risks, the adequacy of existing controls, and the optimum
use of capital to finance those risks. The component
parts are summarized in exhibit 1. However, very often
the process is more about coordinating the activities of
existing functions and individuals, while overlaying more
rigorous financial analysis on which to base management
decisions. At Marsh, we recommend that our clients
follow a three-step process to ensure that they are making
appropriate risk-financing decisions.
Step 1: Understand the strategy and current position
of the business
The strategic direction that a company takes and the
impact of this strategy on its capital allocation should
ultimately underpin the decisions it takes on risk
transfer. It is not enough to say that a company with a
strong cash flow should, de facto, retain more risk. The
company may prefer to invest that capital in new areas
or to issue dividends to shareholders. Equally, it could be
naturally risk averse and feel more comfortable insuring
a greater proportion of its risks than its balance sheet
might otherwise suggest. Companies arrive at their “risk
appetite” through a variety of measures, from the scientific
to gut feel. Whatever the method, it is only when there is
a collective view on the role that risk transfer should take
that an optimum strategy can be developed.
Information is as important as strategy. High-quality
information on the company, its risks, and the quality of
its risk-management controls will play an influential role in
decisions around program structure and investment in risk
control. Important information includes the following:

- Historic claims experience;
- Existing risk registers;
- Business-continuity plans and programs;
- Corporate-governance programs;
- Benchmarked data from industry peer groups;
- Attitudes to risk from the executive board and senior
management group;
- Gaps in required underwriting information; and
- A snapshot of the business risks around the company’s
operating divisions, sites and locations, often
represented in a risk map (see exhibit 2).

This stage of the process is about delivering a clearer
perspective on emerging/expected losses and risk controls,
and in doing so starting to develop quantitative measures
that can be used for future financial analysis. Some
companies use this stage in the process to review whether
their risk-management controls are effective and whether
an investment in improvement might positively affect their
risk profile and subsequent cost of risk.
Step 2: Analyze and model the data
Turning data into meaningful decision-making tools forms
the second, critical stage of the process. The goal of this
stage is to identify the optimal structure for the riskfinancing
program, against which coverage can be overlaid.
This stage is focused not only on identifying optimum
insurance arrangements, but also on determining the
amount and type of risk that can be retained by the
company. Typical considerations in this step include
the following:
- Technically reviewing current coverage, limits and
exclusions to stress test the adequacy of existing
insurance arrangements against the risks identified
in step 1.
- Calculating risk tolerance. This step helps companies
determine their materiality threshold and transfer
“strike points.” A variety of indicators can be used to
help companies understand their willingness to pay for
losses out of their own liquid reserves, which include
credit ratings, materiality thresholds, benchmarked
retention levels by industry or “rules of thumb.”
- Using the analysis on risks, existing insurances and
optimal retention levels to develop actuarial models
– sometimes called integrated loss models – to design
and stress test various program structures. The
objective of this step is to identify the lowest total cost
of risk, allowing for self-insured volatility. The accuracy
of this process can be limited by factors such as longtail
claims or large unidentified future exposures, and
companies use sophisticated risk-modeling techniques,
such as Monte Carlo Simulation, to help compensate for
these variances in losses.
- Analysis of alternative risk-financing options, including
captive insurance companies. Some companies may
decide to set up a captive insurance company to
self-finance some of their risk, with further analysis
required to determine which classes to participate
in, how to structure the captive, and where it should
be domiciled.
Step 3: Design and place risk-financing solutions
Selecting potential insurance markets is a strategic
decision in its own right, and should be governed as
much by performance considerations such as program
administration, serving and security rating, as it is pricing.
Underwriting submissions should contain detailed and
relevant data on the extent of the risks, the performance
of controls and their correlation with losses, and the
commitment of the business to improving its risk profile.The insurance placement will be complemented by
the structure of alternative risk-financing and transfer
solutions to ensure the overall return on capital invested
in risk is optimized for the company.
Case in point – FTSE 250 company reduces cost of risk
by millions of dollars
A FTSE 250 company recently appointed Marsh to carry out
a review of the appropriateness of its insurance program
and its overall approach to buying insurance. There were
a number of reasons why the company thought it the right
time to carry out this review, which included increased
requirements to demonstrate corporate governance and a
major restructure within the business.
The starting place for the review was to undertake a risk
assessment with business leaders across the company
in order to build a risk register. Using this information,
the client was able to compare its perceived exposures
to its actual insurance cover. Having calculated its risk
tolerance, we were able to help the company design the
optimum risk-transfer program and negotiate renewed
coverage with the insurance markets.
This exercise ended up saving the company millions of
dollars in its total cost of risk.
Summary
For most companies, a Risk Transfer Optimization exercise
should not represent a marked change to many of their
existing processes. The more significant change will be the
linking of these activities under one consistent strategy.
Far from this process representing additional bureaucracy,
it should help streamline the way in which a company
finances risk, creating further efficiencies.
The culture, behaviors and attitudes that senior managers
demonstrate toward risk management and insurance
buying will be a major contributor to the success of an
integrated approach. Sometimes it will be worth running
short executive workshops at the outset to help business
leadership understand how business risk management
and insurance fit together, and the benefits that can be
achieved from having a robust approach to optimizing
capital allocation.
The process of Risk Transfer Optimization is increasingly
evolving the way in which companies approach risk
financing. The net result of this should be sustained
financial and business benefits, and opportunities for risk
managers to shine.
Eddie McLaughlin is a managing director at Marsh. He is the U.K. leader of the
firm’s Risk Advisory Group – comprising strategic risk, modeling, quantification,
captive advisory and business continuity management – and the global leader
of the firm’s Modeling Analysis and Design team. He can be reached at
.
Man Cheung is a senior vice president at Marsh. He is the U.K. leader of
the firm’s Modeling, Analysis and Design team and can be reached at
.
John Davies is a managing director in Marsh’s U.K. business. He played a
pivotal role in developing and delivering the firm’s Risk Transfer Optimization
solutions, and continues to work with multinational clients in this area. He can
be reached at .
Richard Waterer is a senior vice president at Marsh and the EMEA sales and
marketing leader for Marsh’s Risk Consulting practice. He can be reached at
.
|